CN106243079A - The Preparation Method And Their Intermediate compound of bicyclol - Google Patents
The Preparation Method And Their Intermediate compound of bicyclol Download PDFInfo
- Publication number
- CN106243079A CN106243079A CN201510304398.2A CN201510304398A CN106243079A CN 106243079 A CN106243079 A CN 106243079A CN 201510304398 A CN201510304398 A CN 201510304398A CN 106243079 A CN106243079 A CN 106243079A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- mixture
- triethylamine
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 69
- KXMTXZACPVCDMH-UHFFFAOYSA-N methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate Chemical compound COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1CO KXMTXZACPVCDMH-UHFFFAOYSA-N 0.000 title abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 14
- -1 methylene-dioxy)-2-methylol-2'-methoxycarbonyl group Chemical group 0.000 claims abstract description 37
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 72
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 30
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 30
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 125000005843 halogen group Chemical group 0.000 claims description 19
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 17
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 16
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 16
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 239000003960 organic solvent Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 230000002140 halogenating effect Effects 0.000 claims description 13
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 239000012320 chlorinating reagent Substances 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- WGJCBBASTRWVJL-UHFFFAOYSA-N 1,3-thiazolidine-2-thione Chemical compound SC1=NCCS1 WGJCBBASTRWVJL-UHFFFAOYSA-N 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- 150000004982 aromatic amines Chemical class 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 239000012279 sodium borohydride Substances 0.000 claims description 7
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 150000001263 acyl chlorides Chemical class 0.000 claims 1
- 238000006197 hydroboration reaction Methods 0.000 claims 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract description 29
- 239000004305 biphenyl Substances 0.000 abstract description 18
- 235000010290 biphenyl Nutrition 0.000 abstract description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 238000006136 alcoholysis reaction Methods 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical class ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- JMZOMFYRADAWOG-UHFFFAOYSA-N methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate Chemical compound COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1C(=O)OC JMZOMFYRADAWOG-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- 0 *C1C=C(*)C(c2c3[U]COc3c(*)cc2*)=C2OC*C12 Chemical compound *C1C=C(*)C(c2c3[U]COc3c(*)cc2*)=C2OC*C12 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- ADVGKWPZRIDURE-UHFFFAOYSA-N 2'-Hydroxyacetanilide Chemical compound CC(=O)NC1=CC=CC=C1O ADVGKWPZRIDURE-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003851 azoles Chemical group 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229950010911 orazamide Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to the Preparation Method And Their Intermediate compound of bicyclol.Specifically, the present invention relates to the bicyclol of formula (1), i.e. 4,4'-dimethoxy-5, the Preparation Method And Their Intermediate compound of double (the methylene-dioxy)-2-methylol-2'-methoxycarbonyl group biphenyl of 6,5', 6'-.
Description
Technical field
The present invention relates to the synthesis of organic compound.Specifically, the present invention relates to the preparation of bicyclol
Method and midbody compound thereof.
Background technology
The present invention relates to bicyclol, i.e. 4,4'-dimethoxy-5, double (the methylene-dioxy)-2-hydroxyl first of 6,5', 6'-
The preparation method of base-2'-methoxycarbonyl group biphenyl, this compound can be used for the auxiliary treatment of chronic hepatopathy.
Bicyclol (Bicyclol sees below formula), chemistry entitled 4,4'-dimethoxy-5, the double (methylene two of 6,5', 6'-
Epoxide)-2-methylol-2'-methoxycarbonyl group biphenyl, it is to carbon tetrachloride, D-Gal amine and right
The acute liver that acetyl aminophenol causes has significant protective effect, can reduce these and move
The transaminase that thing acute liver damage causes raises, and can alleviate liver tissue injury, is now used clinically for
The auxiliary treatment of chronic hepatopathy.
United States Patent (USP) US4868207 and European patent EP 0353358 describe bicyclol and derivant thereof
Preparation method and its pharmacological activity, the preparation method of the bicyclol be given in these patents is as follows:
It is that raw material solves biphenyl acid (6) through alkaline water with bifendate (5), then is dehydrated to obtain biphenyl with acetic anhydride
Anhydride (7), and then with sodium borohydride reduction, lactonize and obtain biphenyl lactone (9) again through p-methyl benzenesulfonic acid,
This lactone finally in methanol in the presence of sodium acetate alcoholysis open loop obtain bicyclol (1).
Although this preparation method reaction condition is gentle, but the alcoholysis open loop yield of biphenyl lactone is relatively low, because of
For column balancing in the presence of reaction, cause reaction end still with the presence of about 55% biphenyl lactone, obtain pair
The yield of cyclic alcohol is only 45%.
Recently, Chinese patent application CN102617544A reports a kind of new bicyclol preparation method,
It is characterized in utilizing intramolecular Ullmann that biphenyl lactone is synthesized, then prepares dicyclo through alcoholysis open loop
Alcohol (1).Although the preparation of biphenyl lactone is improved by the method, but the step for of alcoholysis open loop still
There are the problems referred to above.
There is document (X.Tang et al., Bioorg.Med.Chem.Lett.22 (2012) 2675 recently
2680) report, obtains biphenyl acid mono-methyl (2) after alcoholysis open loop by biphenyl anhydride (7), then with miaow
Azoles forms biphenyl acid mono-methyl Orazamide (13) under condensing agent EDCI effect, then through boron hydrogen
Change sodium reduction and can obtain bicyclol (1).Although it is higher that the method respectively walks yield, but reagent E DCI used
Expensive, and the bicyclol that thus prepared by method remains a need for column chromatography for separation and refines.
Therefore, in sum, mainly with bifendate as raw material in the commercial production of current bicyclol,
Respectively prepared by the alcoholysis open loop through biphenyl lactone or the selective reduction through biphenyl acid mono-methyl, is deposited
Subject matter be that total recovery is relatively low and production cost is higher.Therefore, one applicable industrialization of research
The process route preparing bicyclol there is the highest Social benefit and economic benefit.So, the present invention
For technical problem underlying present in the existing production technology of bicyclol, it is provided that a kind of simple to operate,
The synthetic method that yield is high, with low cost.
Summary of the invention
In the present invention, following term has an implication of the following stated:
Independent or with other moiety combinations terms " alkyl " represent the straight chain being made up of carbon and hydrogen atom
Or the monovalent saturated hydrocarbon group of side chain.“C1-4Alkyl " represent the side chain with 1 to 4 carbon atom
Or straight chained alkyl, such as methyl, ethyl, n-pro-pyl, isopropyl, normal-butyl, sec-butyl, tertiary fourth
Base.
" aryl " refers to the aromatic rings of the monocycle containing carbon atom or condensed-bicyclic.The preferred C of aryl6-10
Aryl.“C6-10Aryl " refer to the aryl containing 6-10 carbon atom.Such as, C6-10Aryl can be
Phenyl or naphthyl.
" aralkyl " refers to the alkyl as above being substituted as described above for aryl groups.
Term " halogen " refers to fluorine, chlorine, bromine or iodine, preferably chlorine, bromine or iodine.
In an embodiment, a kind of method that the invention provides formula (1) compound,
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl,
Described method comprises the steps:
1) carboxyl in formula (2) compound is carried out halo, thus obtains formula (3) compound,
2) carboxylic acid halides of formula (3) compound and 2-mercaptothiazoline are condensed to yield formula (4) in the presence of a base to change
Compound,
3) by formula (4) compound reducing agent, such as metal hydroborating agents reduction obtains formula (1) chemical combination
Thing,
Wherein R1、R2、R3The most as hereinbefore defined, X is halogen.
In step 1) in, described halo is carried out in the presence of halogenating agent.Described halogenating agent
Being such as chlorinating agent or brominated reagent, chlorinating agent includes such as thionyl chloride, oxalyl chloride, trichlorine
Change phosphorus, phosphorus oxychloride etc., preferably thionyl chloride and oxalyl chloride.Reaction dissolvent can be organic non-proton
Solvent or its mixture, such as dichloromethane, 1,2-dichloroethanes, oxolane, toluene or they
Two or more mixture, preferably dichloromethane.
Step 1) in formula (2) compound used can prepare by literature method well known in the prior art, example
As prepared from bifendate.
In step 2) in, described alkali can be trimethylamine, such as triethylamine, diisopropylethylamine
Deng, or organic arylamine, such as pyridine, N, N-lutidines etc., or they two kinds or
Two or more mixture, preferably triethylamine or triethylamine and N, the mixture of N-lutidines.
Reaction dissolvent can be organic aprotic solvents, such as dichloromethane, 1,2-dichloroethanes, chloroform, four
Hydrogen furan, ethyl acetate, toluene, DMF, or their two kinds or two kinds with
On mixture.Reaction temperature can be-5～80 DEG C, preferably 0-45 DEG C.
In step 3) in, metal hydroborating agents can be sodium borohydride, potassium borohydride.Reaction is used
Solvent can be the mixture of organic solvent and water, described organic solvent is miscible with water organic
Solvent, such as oxolane, Isosorbide-5-Nitrae-dioxane, methanol, ethanol or they two or more
Mixture.Organic solvent can be 1/1～20/1, preferably oxolane and the 10/1 of water with the ratio of water
Mixed solvent.Reaction temperature is-5～50 DEG C, preferably 0-45 DEG C.
In a preferred embodiment, the invention provides the side of a kind of formula (1) compound
Method,
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl,
Described method comprises the steps:
1) carboxyl in formula (2) compound is carried out halo, thus obtains formula (3) compound,
2) carboxylic acid halides of formula (3) compound and 2-mercaptothiazoline are condensed to yield formula (4) in the presence of a base to change
Compound,
3) reduction of formula (4) compounds with metal hydroborating agents is obtained formula (1) compound,
Wherein R1、R2、R3The most as hereinbefore defined, X is halogen,
Wherein in step 1) in, described halo is carried out in the presence of halogenating agent, described halo
Reagent is such as chlorinating agent, such as thionyl chloride, oxalyl chloride, Phosphorous chloride., phosphorus oxychloride etc.,
Preferably thionyl chloride or oxalyl chloride；
In step 2) in, described alkali can be trimethylamine, such as triethylamine, diisopropylethylamine
Deng, or organic arylamine, such as pyridine, N, N-lutidines etc., or they two kinds or
Two or more mixture, preferably triethylamine or triethylamine and N, the mixture of N-lutidines；
In step 3) in, metal hydroborating agents can be sodium borohydride or potassium borohydride, and reaction is used
Solvent be the mixture of organic solvent and water, described organic solvent is organic solvent miscible with water,
Such as oxolane, 1,4-dioxane, methanol, ethanol or their two or more mixing
Thing.
It will be understood by those skilled in the art that in above synthetic method, step 1 can be used) extremely
2) reaction that in, the product of any step gained is directly carried out as raw material subsequently carrys out formula (1)
Compound.It is for instance possible to use the compound of formula (3) as raw material and carries out step 2 as above)
To 3) carry out formula (1) compound, or the compound of the formula of employing (4) as raw material and is carried out as mentioned above
Step 3) carry out formula (1) compound.
On the other hand, the invention provides the compound of formula (4),
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl.
In a preferred embodiment, the compound of formula (4) is 7,5 '-(2-sulfur generation of 7 '-dimethoxy
Thiazoline-3-carbonyl)-[4,4 '] double [benzo [1,3] dioxolane]-5-methyl formate, it may be assumed that
On the other hand, the method that the invention provides the compound of formula (4),
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl,
The method includes:
1) carboxyl in formula (2) compound is carried out halo, thus obtains formula (3) compound,
2) carboxylic acid halides of formula (3) compound and 2-mercaptothiazoline are condensed to yield formula (4) in the presence of a base to change
Compound,
Wherein R1、R2、R3The most as hereinbefore defined, X is halogen.
In step 1) in, described halo is carried out in the presence of halogenating agent.Described halogenating agent
Being such as chlorinating agent or brominated reagent, chlorinating agent includes such as thionyl chloride, oxalyl chloride, trichlorine
Change phosphorus, phosphorus oxychloride etc., preferably thionyl chloride and oxalyl chloride.Reaction dissolvent can be organic non-proton
Solvent or its mixture, such as dichloromethane, 1,2-dichloroethanes, oxolane, toluene or they
Two or more mixture, preferably dichloromethane.
Step 1) in formula (2) compound used can prepare by literature method well known in the prior art, example
As prepared from bifendate.
In step 2) in, described alkali can be trimethylamine, such as triethylamine, diisopropylethylamine
Deng, or organic arylamine, such as pyridine, N, N-lutidines etc., or they two kinds or
Two or more mixture, preferably triethylamine or triethylamine and N, the mixture of N-lutidines.
Reaction dissolvent can be organic aprotic solvents, such as dichloromethane, 1,2-dichloroethanes, chloroform, four
Hydrogen furan, ethyl acetate, toluene, DMF, or their two kinds or two kinds with
On mixture.Reaction temperature can be-5～80 DEG C, preferably 0-45 DEG C.
In a preferred embodiment, the method that the invention provides formula (4) compound,
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl,
Described method comprises the steps:
1) carboxyl in formula (2) compound is carried out halo, thus obtains formula (3) compound,
2) carboxylic acid halides of formula (3) compound and 2-mercaptothiazoline are condensed to yield formula (4) in the presence of a base to change
Compound,
Wherein R1、R2、R3The most as hereinbefore defined, X is halogen,
Wherein in step 1) in, described halo is carried out in the presence of halogenating agent, described halo
Reagent is such as chlorinating agent, such as thionyl chloride, oxalyl chloride, Phosphorous chloride., phosphorus oxychloride etc.,
Preferably thionyl chloride or oxalyl chloride；
In step 2) in, described alkali can be trimethylamine, such as triethylamine, diisopropylethylamine
Deng, or organic arylamine, such as pyridine, N, N-lutidines etc., or they two kinds or
Two or more mixture, preferably triethylamine or triethylamine and N, the mixture of N-lutidines.
It will be understood by those skilled in the art that in above synthetic method, the change of formula (3) can be used
Compound is as raw material and carries out step 2 as above) carry out formula (4) compound.
On the other hand, the invention provides the compound of formula (3),
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl；X is halogen.
In a preferred embodiment, the compound of formula (3) is 5 '-chloroformyl-7,7 '-dimethoxy
-[4,4 '] double [benzo [1,3] dioxolane]-5-methyl formate, it may be assumed that
The present invention compared with prior art, has the advantage that
1) reaction condition is gentle, simple to operate.
2) agents useful for same is cheap, is readily available.
3) post-processing approach of each intermediate and product is simple, it is easy to accomplish industrialized production.
Detailed description of the invention
Following example are intended to illustrate the present invention, the scope that should not be construed as limiting the invention.
Initiation material biphenyl acid mono-methyl used by embodiment can be by the literature method of prior art from connection
Benzene dibasic acid esters prepares.2-mercaptothiazoline is commercial reagent, but also can be by well known by persons skilled in the art
Prepared by method.
Embodiment 1:7,7 '-dimethoxy 5 '-(2-thioxothiazole quinoline-3-carbonyl)-[4,4 '] double [benzo [1,3]
Dioxolane]-5-methyl formate (formula (4) compound, wherein R1、R2、R3It is methyl respectively)
Preparation
(1) 5 '-chloroformyl-7,7 '-dimethoxy-[4,4 '] double [benzo [1,3] dioxolane]-5-formic acid
Methyl ester (formula (3) compound, wherein R1、R2、R3It is methyl respectively)
2.0 grams of (5mmol) biphenyl acid mono-methyls (compound 2) are dissolved in 20ml dichloromethane, add
1.5ml (20.8mmol) thionyl chloride and 1 dimethylformamide, be heated to reflux 2 hours, be evaporated,
Obtain title product 2.15g, be directly used in the next step.
(2) 7,7 '-dimethoxy, 5 '-(2-thioxothiazole quinoline-3-carbonyl)-[4,4 '] double [benzo [1,3] dioxas
Pentamethylene .]-5-methyl formate (formula (4) compound, wherein R1、R2、R3Methyl respectively) preparation
The compound 3 that 2.1g (～5mmol) previous step prepares is dissolved in 10ml dichloromethane, ice
It is added drop-wise to containing 0.86g (7.5mmol) 2-mercaptothiazoline and 2.1ml (15mmol) three second under bath cooling
In the 20ml dichloromethane of amine, finish, add 0.1 gram of DMAP, stirred overnight at room temperature.Next day
Add 20ml dchloromethane, wash with 1N NaOH 20ml X 2 successively, washing, anhydrous
Na2SO4It is dried.Filtering, filtrate decompression is evaporated, and obtains yellow solid 2.57 grams (～100%).
1H NMR(300MHz,CDCl3) δ 7.30 (s, 1H), 7.26 (s, 1H), 6.03～6.08 (m,
4H), 4.16～4.25 (m, 2H), 3.96 (s, 6H), 3.66 (s, 3H)；2.79～2.99 (m, 2H)
Double (the methylene-dioxy)-2-methylol-2'-methoxy carbonyl of embodiment 2:4,4'-dimethoxy-5,6,5', 6'-
Base biphenyl (formula (1) compound, wherein R1、R2、R3Methyl respectively) preparation；
Being dissolved in 5ml oxolane by 500mg (1mmol) compound 4, ice bath cools down, and controls temperature
Spend 0～5 DEG C of under agitation dropping containing 95mg (2.5mmol) sodium borohydride, the 5ml of 0.2ml water
Tetrahydrofuran solution.Finish, be incubated and stir 30 minutes at 0～5 DEG C, then heat to 30～35 DEG C and stir
Mixing 30 minutes, reactant liquor is become colorless by yellow, and TLC display raw material speckle disappears.Then add dilute
Hydrochloric acid removes the sodium borohydride of excess, and oxolane is evaporated under reduced pressure, and residue dichloromethane dissolves,
Use 5%Na successively2CO3Wash, washing, anhydrous Na2SO4It is dried.Filtering, filtrate decompression is evaporated,
Obtain white solid 310mg, for title compound.
1H NMR(300MHz,CDCl3) δ 7.32 (s, 1H), 6.76 (s, 1H), 5.90～～6.03 (m,
4H), 4.32～4.41 (dd, 2H), 3.96 (s, 3H), 3.94 (s, 3H)；3.70(s,3H)
ESI-MS m/z:413[M+Na]+。
Above-mentioned white solid 310mg 10ml re-crystallizing in ethyl acetate, filters, dries to obtain 270mg.
Mp:136 DEG C-141 DEG C.
Claims (17)
1. the method for formula (1) compound,
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl,
Described method comprises the steps:
1) carboxyl in formula (2) compound is carried out halo, thus obtains formula (3) compound,
2) carboxylic acid halides of formula (3) compound and 2-mercaptothiazoline are condensed to yield formula (4) in the presence of a base to change
Compound,
3) by formula (4) compound reducing agent, such as metal hydroborating agents reduction obtains formula (1) chemical combination
Thing,
Wherein R1、R2、R3The most as hereinbefore defined, X is halogen.
Method the most according to claim 1, wherein in step 1) in, described halo is at halogen
For carry out in the presence of reagent, described halogenating agent is such as chlorinating agent, such as thionyl chloride, grass
Acyl chlorides, Phosphorous chloride., phosphorus oxychloride etc., preferably thionyl chloride or oxalyl chloride.
Method the most according to claim 1 and 2, wherein in step 2) in, described alkali is permissible
It is trimethylamine, such as triethylamine, diisopropylethylamine etc., or organic arylamine, such as pyridine,
N, N-lutidines etc., or the mixture of they two or more, preferably triethylamine or
Person's triethylamine and N, the mixture of N-lutidines.
4. according to the method for any one of the claims, wherein in step 3) in, metal hydroboration tries
Agent can be sodium borohydride or potassium borohydride, and the solvent used by reaction is the mixture of organic solvent and water,
Described organic solvent is organic solvent miscible with water, such as oxolane, Isosorbide-5-Nitrae-dioxane, methanol,
Ethanol or their two or more mixture.
5. according to the method for any one of the claims, wherein:
In step 1) in, described halo is carried out in the presence of halogenating agent, described halogenating agent
It is such as chlorinating agent, such as thionyl chloride, oxalyl chloride, Phosphorous chloride., phosphorus oxychloride etc., preferably
Thionyl chloride or oxalyl chloride；
In step 2) in, described alkali is trimethylamine, such as triethylamine, diisopropylethylamine etc.,
Or organic arylamine, such as pyridine, N, N-lutidines etc., or their two kinds or two kinds
Above mixture, preferably triethylamine or triethylamine and N, the mixture of N-lutidines；And
In step 3) in, metal hydroborating agents is sodium borohydride or potassium borohydride, molten used by reaction
Agent is the mixture of organic solvent and water, and described organic solvent is organic solvent miscible with water, example
Such as oxolane, 1,4-dioxane, methanol, ethanol or their two or more mixture.
6. according to the method for any one of the claims, wherein in step 3) in solvent used be to have
The mixture of machine solvent and water, organic solvent is 1/1～20/1 with the ratio of water, preferably oxolane and
10/1 mixed solvent of water.
7., according to the method for any one of the claims, wherein use the compound of formula (3) as raw material
And carry out step 2 as above) to 3) carry out formula (1) compound.
8., according to the method for any one of the claims, wherein use the compound of formula (4) as raw material
And carry out step 3 as above) carry out formula (1) compound.
9. the compound of formula (4),
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl.
Compound the most according to claim 9, it is 7,7 '-dimethoxy, 5 '-(2-thioxothiazole quinoline-3-
Carbonyl)-[4,4 '] double [benzo [1,3] dioxolane]-5-methyl formate, structure is as follows:
The method of 11. formulas (4) compound,
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl,
The method includes:
1) carboxyl in formula (2) compound is carried out halo, thus obtains formula (3) compound,
2) carboxylic acid halides of formula (3) compound and 2-mercaptothiazoline are condensed to yield formula (4) in the presence of a base to change
Compound,
Wherein R1、R2、R3The most as hereinbefore defined, X is halogen.
12. methods according to claim 11, wherein in step 1) in, described halo be
Carrying out in the presence of halogenating agent, described halogenating agent is such as chlorinating agent, such as thionyl chloride,
Oxalyl chloride, Phosphorous chloride., phosphorus oxychloride etc., preferably thionyl chloride or oxalyl chloride.
13. according to the method described in claim 11 or 12, wherein in step 2) in, described alkali
It is trimethylamine, such as triethylamine, diisopropylethylamine etc., or organic arylamine, such as pyridine,
N, N-lutidines etc., or the mixture of they two or more, preferably triethylamine or
Person's triethylamine and N, the mixture of N-lutidines.
14. according to the method described in any one of claim 11-13, wherein:
In step 1) in, described halo is carried out in the presence of halogenating agent, described halogenating agent
It is such as chlorinating agent, such as thionyl chloride, oxalyl chloride, Phosphorous chloride., phosphorus oxychloride etc., preferably
Thionyl chloride or oxalyl chloride；And
In step 2) in, described alkali is trimethylamine, such as triethylamine, diisopropylethylamine etc.,
Or organic arylamine, such as pyridine, N, N-lutidines etc., or their two kinds or two kinds
Above mixture, preferably triethylamine or triethylamine and N, the mixture of N-lutidines.
15., according to the method described in any one of claim 11-14, wherein use the compound of formula (3)
As raw material and carry out step 2 as above) carry out formula (4) compound.
The compound of 16. formulas (3),
Wherein R1、R2、R3It is each independently selected from alkyl or aralkyl, preferably C1-4Alkyl, example
Such as methyl；X is halogen.
17. compounds according to claim 16, it is 5 '-chloroformyl-7,7 '-dimethoxy-[4,4 ']
Double [benzo [1,3] dioxolane]-5-methyl formate, structure is as follows:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510304398.2A CN106243079B (en) | 2015-06-04 | 2015-06-04 | The Preparation Method And Their Intermediate compound of bicyclic alcohols |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510304398.2A CN106243079B (en) | 2015-06-04 | 2015-06-04 | The Preparation Method And Their Intermediate compound of bicyclic alcohols |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106243079A true CN106243079A (en) | 2016-12-21 |
| CN106243079B CN106243079B (en) | 2019-02-15 |
Family
ID=57626485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510304398.2A Active CN106243079B (en) | 2015-06-04 | 2015-06-04 | The Preparation Method And Their Intermediate compound of bicyclic alcohols |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106243079B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111205263A (en) * | 2020-04-22 | 2020-05-29 | 北京鑫开元医药科技有限公司 | Preparation method and application of bicyclol |
| CN113754627A (en) * | 2021-09-03 | 2021-12-07 | 西北师范大学白银师科创新研究院 | A kind of preparation method of biphenyl alcohol |
| CN116283886A (en) * | 2021-12-20 | 2023-06-23 | 重庆圣华曦药业股份有限公司 | Preparation method of bicyclo-ethanol and application of bicyclo-ethanol in bicyclo-ethanol tablet |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1837203A (en) * | 2006-03-07 | 2006-09-27 | 河南省科学院质量检验与分析测试研究中心 | Chiral 4,4'-dimethoxy-5,6,5',6'-bis methylene dioxy -2,2'-phthalic acid derivatives and process for preparing same |
| CN103058982A (en) * | 2011-10-19 | 2013-04-24 | 四川大学 | Bifendate derivative containing halogen substituent, preparation method and application |
-
2015
- 2015-06-04 CN CN201510304398.2A patent/CN106243079B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1837203A (en) * | 2006-03-07 | 2006-09-27 | 河南省科学院质量检验与分析测试研究中心 | Chiral 4,4'-dimethoxy-5,6,5',6'-bis methylene dioxy -2,2'-phthalic acid derivatives and process for preparing same |
| CN103058982A (en) * | 2011-10-19 | 2013-04-24 | 四川大学 | Bifendate derivative containing halogen substituent, preparation method and application |
Non-Patent Citations (2)
| Title |
|---|
| GU, XIAOKE等: ""Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors"", 《BIOORGANIC & MEDICINAL CHEMISTRY》 * |
| KONG, XIANG-WEN等: ""Synthesis and Cytotoxic Evaluation of Novel Dimethyl [1,1′-Biphenyl]-2,2′-dicarboxylates Bearing 1,3,4-Thiadiazole Moieties"", 《CHEMISTRY & BIODIVERSITY》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111205263A (en) * | 2020-04-22 | 2020-05-29 | 北京鑫开元医药科技有限公司 | Preparation method and application of bicyclol |
| CN113754627A (en) * | 2021-09-03 | 2021-12-07 | 西北师范大学白银师科创新研究院 | A kind of preparation method of biphenyl alcohol |
| CN116283886A (en) * | 2021-12-20 | 2023-06-23 | 重庆圣华曦药业股份有限公司 | Preparation method of bicyclo-ethanol and application of bicyclo-ethanol in bicyclo-ethanol tablet |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106243079B (en) | 2019-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104557572B (en) | Levalbuterol intermediate and levalbuterol hydrochloride synthesis method | |
| WO2009099868A1 (en) | Process for the preparation of (-) -delta 9-tetrahydrocannabinol | |
| CN106188062A (en) | Replace the preparation method of Buddhist nun according to Shandong, replace intermediate and the preparation method of intermediate of Buddhist nun according to Shandong | |
| CN105229019B (en) | The Preparation Method And Their Intermediate of Epi-ADM | |
| JP2015067606A (en) | Process for producing 2-hydroxymethyl-2,3-dihydro-thieno [3,4-b] [1,4] dioxin | |
| CN106243079A (en) | The Preparation Method And Their Intermediate compound of bicyclol | |
| CN110183445B (en) | Synthetic method of moxifloxacin and its derivatives | |
| CN104177331B (en) | The preparation method of bilastine | |
| CN101346373A (en) | 2,2',6,6' -tetraoxazoline biphenyl ligand and preparation method thereof | |
| CN101247806B (en) | SnAr process for preparing benzimidazole compounds | |
| CN105175346B (en) | A kind of method of synthesizing rosuvastatin spit of fland calcium intermediate | |
| JP2008266172A (en) | Method for producing 3-o-alkyl-5,6-o-(1-methylethylidene)-l-ascorbic acid and method for producing 5,6-o-(1-methylethylidene)-l-ascorbic acid | |
| CN113416142B (en) | Preparation method of 5-ALA intermediate 5-bromolevulinate | |
| CN102786541A (en) | Preparation method and application of potassium (iso)quinoline thifluoroborate | |
| CN109553595A (en) | A kind of Preparation Method And Their Intermediate of chiral gamma-butyrolactone | |
| CN106749156B (en) | Process for preparing benzo [1,3-d ] dioxoles and intermediates thereof | |
| CN106432328B (en) | A kind of preparation method of Suo Feibuwei intermediate | |
| CN112679519B (en) | Polycyclic carbamoyl pyridone analogues and their preparation and use | |
| CN113773294B (en) | Preparation method and application of flavonoids and isoflavones | |
| JPWO2015012271A1 (en) | Method for producing heterocyclic compound | |
| JP5280858B2 (en) | 1,1'-Biphenyls Axial Chirality Ligand Linked at 5,5 'Position and Method for Producing the Same | |
| CN116239562B (en) | A method for synthesizing doxepin hydrochloride using benzofuranone as raw material | |
| CN111747874B (en) | Ericoxib intermediate and preparation method and application thereof | |
| CN111747873B (en) | Ericoxib intermediate and preparation method and application thereof | |
| CN108314689A (en) | 4,11- diacyl bergenin derivative synthetic methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |